Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

Title
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic
Authors
Keywords
Breast cancer, COVID-19, Genetic counseling, Genetic testing, Hereditary breast and ovarian cancer syndrome, Ovarian cancer
Journal
European Journal of Medical Genetics
Volume 63, Issue 12, Pages 104098
Publisher
Elsevier BV
Online
2020-11-11
DOI
10.1016/j.ejmg.2020.104098

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started